1.
Short-Term Outcomes of Bimatoprost Sustained-Release Intracameral Implant in Glaucoma.
Wong Michael K, Bowers Mallory E, Ventimiglia Jonas, Niknam Rachel M, Moster Marlene R, Pro Michael J et al.
J GlaucomaJul 20230 citationsCase Series
This study found intracameral Bimatoprost SR significantly lowered IOP and medication use in glaucoma patients, offering an effective treatment option even after prior SLT.